Personal information

Verified email domains

Activities

Employment (2)

National Institute of Infectious Diseases: Tokyo, JP

2021-01-01 to present | Researcher (Pathology)
Employment
Source: Self-asserted source
Sho Miyamoto

Kyoto University: Kyoto, JP

2019-04-01 to 2021-03-31 | JSPS Research Fellow DC2
Employment
Source: Self-asserted source
Sho Miyamoto

Funding (2)

The intranuclear site of influenza virus replication

2021-04 to 2022-03 | Grant
Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University (Kyoto, JP)
GRANT_NUMBER: 2021-2-1
Source: Self-asserted source
Sho Miyamoto

Ultrastructural analysis of an eight-genomic segment complex within an influenza virion

2019-04 to 2021-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 19J14928
Source: Self-asserted source
Sho Miyamoto

Works (34)

Interpreting the Influence of Using Blood Donor Residual Samples for SARS-CoV-2 Seroprevalence Studies in Japan: Cross-Sectional Survey Study

JMIR Public Health and Surveillance
2025-02-10 | Journal article
Contributors: Ryo Kinoshita; Sho Miyamoto; Tadaki Suzuki; Motoi Suzuki; Daisuke Yoneoka
Source: check_circle
Crossref

Acute acalculous cholecystitis following extended administration of nirmatrelvir/ritonavir for persistent SARS-CoV-2 infection

Journal of Infection and Chemotherapy
2024 | Journal article
EID:

2-s2.0-85181899409

Part of ISSN: 14377780 1341321X
Contributors: Ito, W.; Fukumori, T.; Asaoka, N.; Imakita, N.; Nishimura, T.; Furukawa, R.; Nishihara, Y.; Fujikura, H.; Sekine, T.; Yamaguchi, N. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses

PLoS ONE
2024 | Journal article
EID:

2-s2.0-85188907335

Part of ISSN: 19326203
Contributors: Nagasawa, S.; Hirata, Y.; Miyamoto, S.; Ozono, S.; Iida, S.; Katano, H.; Tsuneya, S.; Kira, K.; Kobayashi, S.; Nakajima, M. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2

Cytokine
2024 | Journal article
EID:

2-s2.0-85189809421

Part of ISSN: 10960023 10434666
Contributors: Kawata, D.; Iwai, H.; Oba, S.; Komiya, Y.; Koike, R.; Miyamoto, S.; Kanno, T.; Ainai, A.; Suzuki, T.; Hosoya, T. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development

Vaccine
2024 | Journal article
EID:

2-s2.0-85185545415

Part of ISSN: 18732518 0264410X
Contributors: Miyamoto, S.; Suzuki, T.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.

NEJM evidence
2024-02 | Journal article
Contributors: Morino E; Mine S; Tomita N; Uemura Y; Shimizu Y; Saito S; Suzuki T; Okumura N; Iwasaki H; Terada J et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central

Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling

medRxiv
2023 | Other
EID:

2-s2.0-85150326504

Contributors: Miyamoto, S.; Kuroda, Y.; Kanno, T.; Ueno, A.; Shiwa-Sudo, N.; Iwata-Yoshikawa, N.; Sakai, Y.; Nagata, N.; Arashiro, T.; Ainai, A. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection

Proceedings of the National Academy of Sciences of the United States of America
2023 | Journal article
EID:

2-s2.0-85181013877

Part of ISSN: 10916490 00278424
Contributors: Miyamoto, S.; Nishiyama, T.; Ueno, A.; Park, H.; Kanno, T.; Nakamura, N.; Ozono, S.; Aihara, K.; Takahashi, K.; Tsuchihashi, Y. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula

Scientific Reports
2023 | Journal article
EID:

2-s2.0-85148115138

Part of ISSN: 20452322
Contributors: Suzuki, T.; Morioka, S.; Yamamoto, K.; Saito, S.; Iida, S.; Teruya, K.; Takasaki, J.; Hojo, M.; Hayakawa, K.; Kutsuna, S. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

National seroepidemiological study of COVID-19 after the initial rollout of vaccines: Before and at the peak of the Omicron-dominant period in Japan

Influenza and other Respiratory Viruses
2023 | Journal article
EID:

2-s2.0-85148779538

Part of ISSN: 17502659 17502640
Contributors: Arashiro, T.; Arai, S.; Kinoshita, R.; Otani, K.; Miyamoto, S.; Yoneoka, D.; Kamigaki, T.; Takahashi, H.; Hibino, H.; Okuyama, M. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization

iScience
2023 | Journal article
EID:

2-s2.0-85147216018

Part of ISSN: 25890042
Contributors: Miyamoto, S.; Arashiro, T.; Ueno, A.; Kanno, T.; Saito, S.; Katano, H.; Iida, S.; Ainai, A.; Ozono, S.; Hemmi, T. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval

iScience
2023 | Journal article
EID:

2-s2.0-85153801674

Part of ISSN: 25890042
Contributors: Miyamoto, S.; Kuroda, Y.; Kanno, T.; Ueno, A.; Shiwa-Sudo, N.; Iwata-Yoshikawa, N.; Sakai, Y.; Nagata, N.; Arashiro, T.; Ainai, A. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.

Proceedings of the National Academy of Sciences of the United States of America
2023-05 | Journal article
Contributors: Hosoya T; Oba S; Komiya Y; Kawata D; Kamiya M; Iwai H; Miyamoto S; Kataoka M; Tobiume M; Kanno T et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Apple-shaped obesity; a risky soil for cytokine-accelerated severity in COVID-19

Research Square
2022 | Other
EID:

2-s2.0-85167497810

Contributors: Hosoya, T.; Oba, S.; Komiya, Y.; Kawata, D.; Kamiya, M.; Iwai, H.; Miyamoto, S.; Kataoka, M.; Tobiume, M.; Kanno, T. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.

Vaccine
2022-08 | Journal article
Contributors: Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Viral load and timing of infection define neutralization diversity to SARS-CoV-2 infection

2022-06 | Preprint
Contributors: Miyamoto S; Arashiro T; Ueno A; Kanno T; Saito S; Katano H; Iida S; Ainai A; Ozono S; Hemmi T et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

2022-05 | Preprint
Contributors: Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2022-04 | Journal article
Contributors: Kamegai K; Iwamoto N; Togano T; Maeda K; Takamatsu Y; Miyazato Y; Ishikane M; Mizokami M; Sugiyama M; Iida S et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.

Emerging infectious diseases
2022-03 | Journal article
Contributors: Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.

Med (New York, N.Y.)
2022-03 | Journal article
Contributors: Miyamoto S; Arashiro T; Adachi Y; Moriyama S; Kinoshita H; Kanno T; Saito S; Katano H; Iida S; Ainai A et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Contribution of RNA-RNA Interactions Mediated by the Genome Packaging Signals for the Selective Genome Packaging of Influenza A Virus

Journal of Virology
2022-03-23 | Journal article
Contributors: Sho Miyamoto; Yukiko Muramoto; Keiko Shindo; Yoko Fujita-Fujiharu; Takeshi Morikawa; Ryoma Tamura; Jamie L. Gilmore; Masahiro Nakano; Takeshi Noda; Stacey Schultz-Cherry
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Migration of Influenza Virus Nucleoprotein into the Nucleolus Is Essential for Ribonucleoprotein Complex Formation

mBio
2022-02-22 | Journal article
Contributors: Sho Miyamoto; Masahiro Nakano; Takeshi Morikawa; Ai Hirabayashi; Ryoma Tamura; Yoko Fujita-Fujiharu; Nanami Hirose; Yukiko Muramoto; Takeshi Noda; Rachel Fearns
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Migration of Influenza Virus Nucleoprotein into the Nucleolus Is Essential for Ribonucleoprotein Complex Formation

mBio
2022-01 | Journal article
Contributors: Miyamoto S; Nakano M; Morikawa T; Hirabayashi A; Tamura R; Fujita-Fujiharu Y; Hirose N; Muramoto Y; Noda T
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central

Propagation of Activated B Cells by In Vitro Severe Fever With Thrombocytopenia Syndrome Virus Infection of Human Peripheral Blood Mononuclear Cells.

The Journal of infectious diseases
2022-01 | Journal article
Contributors: Wada Y; Miyamoto S; Iida S; Sano K; Sato Y; Ainai A; Saito K; Katano H; Hasegawa H; Suzuki T
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

2022-01 | Preprint
Contributors: Miyamoto S; Arashiro T; Adachi Y; Moriyama S; Kinoshita H; Kanno T; Saito S; Katano H; Iida S; Ainai A et al.
Source: Self-asserted source
Sho Miyamoto via Europe PubMed Central
grade
Preferred source (of 2)‎

Ultrastructure of influenza virus ribonucleoprotein complexes during viral RNA synthesis

Communications Biology
2021 | Journal article
EID:

2-s2.0-85109642497

Part of ISSN: 23993642
Contributors: Nakano, M.; Sugita, Y.; Kodera, N.; Miyamoto, S.; Muramoto, Y.; Wolf, M.; Noda, T.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections

Research Square
2021 | Other
EID:

2-s2.0-85168027333

Contributors: Arashiro, T.; Kanno, T.; Miyamoto, S.; Saito, S.; Moriyama, S.; Sekizuka, T.; Kanou, K.; Stucky, A.; Iida, S.; Ainai, A. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections

ResearchSquare
2021 | Other
EID:

2-s2.0-85132387656

Contributors: Arashiro, T.; Kanno, T.; Miyamoto, S.; Saito, S.; Moriyama, S.; Sekizuka, T.; Kanou, K.; Stucky, A.; Iida, S.; Ainai, A. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor

Viruses
2021-09-03 | Journal article
Contributors: Toru Takenaga; Zihan Zhang; Yukiko Muramoto; Sarah Katharina Fehling; Ai Hirabayashi; Yuki Takamatsu; Junichi Kajikawa; Sho Miyamoto; Masahiro Nakano; Shuzo Urata et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Influenza virus ribonucleoprotein complex formation occurs in the nucleolus

2021-02-24 | Preprint
Contributors: Sho Miyamoto; Masahiro Nakano; Takeshi Morikawa; Ai Hirabayashi; Ryoma Tamura; Yoko Fujita; Nanami Hirose; Yukiko Muramoto; Takeshi Noda
Source: check_circle
Crossref

In vitro vRNA–vRNA interactions in the H1N1 influenza A virus genome

Microbiology and Immunology
2020-03 | Journal article
Contributors: Sho Miyamoto; Takeshi Noda
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

vRNA-vRNA interactions in influenza A virus HA vRNA packaging

2020-01-16 | Preprint
Contributors: Sho Miyamoto; Yukiko Muramoto; Keiko Shindo; Yoko Fujita; Takeshi Morikawa; Ryoma Tamura; Jamie L Gilmore; Masahiro Nakano; Takeshi Noda
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Generation of a purely clonal defective interfering influenza virus

Microbiology and immunology
2019 | Journal article
EID:

2-s2.0-85067902994

Contributors: Yamagata, Y.; Muramoto, Y.; Miyamoto, S.; Shindo, K.; Nakano, M.; Noda, T.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier

N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation

Nature Microbiology
2019 | Journal article
EID:

2-s2.0-85071325828

Contributors: Yamasoba, D.; Sato, K.; Ichinose, T.; Imamura, T.; Koepke, L.; Joas, S.; Reith, E.; Hotter, D.; Misawa, N.; Akaki, K. et al.
Source: Self-asserted source
Sho Miyamoto via Scopus - Elsevier